Connect with us

Science & Technology

Detecting Cancer – Can You Trust All the Tests?

Obviously, a false diagnosis of cancer would be a disaster.

I’m not talking about all tests for cancer. I’ve only looked into two. This is what I’ve discovered.

There is a blood test, which looks for a bio-marker labeled CA125. There are doctors who will tell you that a highly positive result indicates a high probability of cancer.

Imagine being a patient on the receiving end of that news.

But wait. If you go to other sources—and no, I’m not talking about alternative practitioners, I’m talking about the mainstream—you’ll get a distinctly different view.

How about a quite prestigious organization—the Mayo Clinic?

“A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood.”

“A CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease.”

“A CA 125 test isn’t accurate enough to use for ovarian cancer screening in general because many noncancerous conditions can increase the CA 125 level.”

“Many different conditions can cause an increase in CA 125, including normal conditions, such as menstruation, and noncancerous conditions, such as uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers.”

“Your doctor may recommend a CA 125 test for several reasons: But such monitoring hasn’t been shown to improve the outcome for those with ovarian cancer, and it might lead to additional and unnecessary rounds of chemotherapy or other treatments.”

“…some people with ovarian cancer may not have an increased CA 125 level. And no evidence shows that screening with CA 125 decreases the chance of dying of ovarian cancer. An elevated level of CA 125 could prompt your doctor to put you through unnecessary and possibly harmful tests.”

“A number of normal and noncancerous conditions can cause an elevated CA 125 level, including:
• Endometriosis
• Liver disease
• Menstruation
• Pelvic inflammatory disease
• Pregnancy
• Uterine fibroids”

“None of the major professional organizations recommend using the CA125 as a screening test for those with an average risk of ovarian cancer.”

Is that clear enough? I hope so.

Let’s move on to another test for cancer. It’s a version of a PET scan.

From, About PET Scans: “A PET scan uses a small amount of a radioactive drug, or tracer, to show differences between healthy tissue and diseased tissue. The most commonly used tracer is called FDG (fluorodeoxyglucose), so the test is sometimes called an FDG-PET scan. Before the PET scan, a small amount of FDG is injected into the patient…”

The theory goes this way: cancer cells have an affinity for FDG and “grab on to” it. Thus, these cancer cells “light up” on the PET scan and can easily be seen. Tumors and metastases can be observed.

Yes, but…

Introduction to PET/CT Imaging: “Cancer cells are not always the only ‘PET avid cells’ (or cells that take up the FDG) in the body. It is important to remember that a PET scan is not able to distinguish metabolic activity due to tumor from activity due to non cancerous processes, such as inflammation or infection.”

PET scan findings can be false positive: “In cancer cells, there is an overproduction of glucose transporters and, as a result, increased FDG uptake. However, not all PET-positive lesions are cancer, and in many instances, PET findings can be false positive. … Inflammatory cells also have increased metabolic rates and, as a result, are FDG avid.”

“Many of us have had patients or know of patients who were treated by the medical oncologist for stage IV cancer only to find out what was assumed to be a metastatic lesion was benign on pathology. Other patients have undergone multiple biopsies of supposed metastatic mesenteric lymph nodes that subsequently turned out to be fat necrosis or a granulomatous reaction. FDG-positive lesions often mean cancer, but not always. A variety of lesions have increased FDG radiotracer [the “lighting up” phenomenon] including infection, inflammation, autoimmune processes, sarcoidosis, and benign tumors. If such conditions are not identified accurately and in a timely manner, misdiagnosis can lead to inadequate therapies.”

Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging: Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging“Glucose however acts as a basic energy substrate for many tissues, and so 18F-FDG activity can be seen both physiologically and in benign conditions. In addition, not all tumors take up FDG [3–5]. The challenge for the interpreting physician is to recognize these entities and avoid the many pitfalls associated with 18F-FDG PET-CT imaging.”

The question is, after a patient is told he has received a positive PET scan, indicating cancer, will the physician spell out all the factors that could have made the test read FALSELY POSITIVE? Will an intelligent and honest and informed conversation take place, or will the doctor shove the test results at the patient and declare: “You have cancer.”

And if that cancer diagnosis is given, will the patient be in a position to voice questions through prior knowledge, and undertake a reasonable dialogue with his doctor?

How do doctors normally hand down test findings? In a balanced way, or from on high, with all the presumed authority of unchallengeable experts?

Are there doctors who don’t even know these two diagnostic tests are rife with falsely positive readings? Yes, there are. And if they deliver papal edicts based on their ignorance, they can cause great harm.

About the Author

Jon Rappoport is the author of three explosive collections, THE MATRIX REVEALEDEXIT FROM THE MATRIX, and POWER OUTSIDE THE MATRIX, Jon was a candidate for a US Congressional seat in the 29thDistrict of California. He maintains a consulting practice for private clients, the purpose of which is the expansion of personal creative power. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world. You can sign up for his free emails at or OutsideTheRealityMachine.

(To read about Jon’s mega-collection, Exit From The Matrixclick here.)

This article (Detecting Cancer – Can You Trust All the Tests?) was originally created and published by Jon Rappaport’s Blog and is re-posted here with permission.

Source link

Science & Technology

20 scientific predictions for the next 10 years

We are lucky to be born and live in an incredible time of development of science and technology. We know the approximate rate of development of both, but we have no idea what this rate will be by the end of our life. Things that have long been considered science fiction are becoming components of our lives every day. In the next ten years, the world may present us with gifts that cannot be refused.

The amazing thing about all these scientific discoveries is that they give rise to technologies that further accelerate technological progress. Our ability to innovate grows exponentially as the years go by. 

To give you an idea of ​​the significance of this progression, here are 20 scientific predictions that should occur by 2030.

1. Artificial intelligence (AI) will pass the Turing test, or in other words, the machine will prove that it can think independently.

2. Hyperloop (Elon Musk’s vacuum train project) will start passenger transportation.

3. Biosensors will go on sale, which will call an ambulance if the wearer suddenly becomes ill. In addition, they will remind you to take certain medications, assessing the current state of the body.

4. The level of air pollution will rise, but scientists will come closer to an effective solution to this global problem.

5. Self-driving car will remain a luxury.

6. The world average cost of solar panels will drop sharply, the transition to solar energy will be very rapid.

7. People will return to the moon and begin its consistent colonization.

8. Robots-killers (drones with weapons) will appear. Crime will reach a fundamentally new level. Investigations will come to a standstill.

9. In developed countries, life expectancy will rise sharply. Cancer will cease to be a fatal problem.

10. NASA’s James Webb Space Telescope will be launched, which will help discover hundreds of new earth-like planets and partially learn the chemical composition of their atmospheres.

11. Rapid development of the multi-billion dollar space tourism industry.

12. In the public domain there will be “sources” for printing clothes on a 3D printer. Tens of millions of workers from poor countries will be left without even this low-paying job.

13. If breast cancer is detected on time, the chance of cure will be 100%.

14. The United States will actively grow organs from stem cells from patients themselves. The donation will in fact be liquidated.

15. We will not find extraterrestrial life on Mars. We will probably find it on the moons of Jupiter or Saturn.

16. SpaceX regularly brings people into lunar orbit in preparation for a manned mission to Mars.

17. Global warming will release the oldest viruses. The Chinese coronavirus will seem like a childish joke.

18. The Internet will completely replace television and print media.

19. Tesla cars will become the world’s best-selling cars.

20. Mass DNA editing experiments will begin. Thanks to this, children will be born with “built-in” protection against a huge number of diseases.

Continue Reading

Science & Technology

Designer has created a concept for the electric bike of the future

Futuristic motorcycles have become part of popular culture, associated with the concepts of the near future. They appeared in the film ” Tron: Legacy”, the anime “Akira” and in many video games from the “cyberpunk” genre. Recently, Russian designer Roman Dolzhenko presented his version of the bike of the future.

Russian designer has created a concept for the electric bike of the

MIMIC eBike – the concept of an electric superbike – originally existed as a sketch on a paper napkin. Later, the designer made the idea more realistic by rendering in 3DS max.

Minimalism prevails in motorcycle design. It lacks straight lines and protrusions. The dashboard of the bike is completely digital, and consists of a solid display showing basic information (speed and battery charge status).


There are very few details about the superbike. Social network users are most often concerned about the question: how to turn the steering wheel with this design? The front wheel fairing and handlebar structure appear to be inactive. In an interview for InceptiveMind, Dolzhenko answered this question: the front of the motorcycle turns completely, but at a slight angle.


There is no information on the cost of transport, capacity and production, which is not surprising. MIMIC eBike is just an extremely realistic concept art of the motorcycle of the future. Perhaps in a couple of years, some Elon Musk will adapt the MIMIC design for a real electric superbike.

Continue Reading

Science & Technology

Genes work differently in men and women

All of our cells have the same genes. They can have mutations, however, both in the muscle cell and in the neuron there is a gene for the globin protein, an insulin gene, an acetylcholinesterase gene, etc. But is it worth reminding that a muscle cell is not like a nerve cell? The point is that genes work differently in different cells.

… although these differences should not be exaggerated – even the end sections of chromosomes, which determine biological age, look the same in men and women.

More than ten years ago, a large international team of researchers launched the GTEx (Genotype-Tissue Expression) project, the goal of which was to determine the activity of all genes in all human tissues and organs. Samples of 49 tissues were taken from 838 donors – dead healthy people, mostly elderly. First of all, the DNA was read from each of the donors. Second, the amount of different RNA was analyzed in each tissue. As you know, genetic information from genes in DNA is first read into the messenger RNA (mRNA) molecule, and then proteins are already synthesized on the mRNA molecule (for simplicity, we are not talking about a large class of RNAs that do not encode proteins and which themselves perform various important functions in the cell). The more active a gene is, the more mRNA is read from it. Therefore, by the level of different mRNAs, one can understand where which genes are more active,

The activity of a gene depends on special regulatory sequences, which are also recorded in the DNA – that is, some sections of DNA affect others. By comparing the genetic text in DNA with the amount of different RNAs in different people, one can understand which regulatory regions in DNA affect a particular gene. Such regions (or loci) in DNA are called eQTL, expression quantitative trait loci, which can be roughly translated as loci that determine the level of activity.

As a result of the work, a whole bundle of fifteen articles was recently published in Science , Science Advances , Cell and other journals. Now, using the map of tissue genetic activity for each gene, you can check how it should work in a particular organ or part of it (because several samples were taken from each organ). On the other hand, by looking for a regulatory region (eQTL) in a person’s genome, one can estimate how certain genes will work. It’s genes – because each regulatory eQTL affects more than two genes.

Another important result concerns telomeres, the ends of chromosomes that shorten with each cell division. Telomeres are often used to assess biological age: the shorter they are, the older the body is. But usually blood cells are taken to measure telomeres. What if different fabrics age differently?

The researchers estimated the length of the end sections of chromosomes in 23 tissues, and came to the conclusion that blood does indeed provide an indication of age in general: telomeres in blood cells shorten in proportion to telomeres in other tissues. At the same time, earlier studies were not confirmed, in which female telomeres were on average longer than male ones – that is, neither women nor men have telomere advantages. Which is curious in its own way, since it is believed that women generally live longer than men . This is probably because telomeres are a significant, but not the only indicator of age. In addition, it was not possible to see a strong shortening of telomeres in smokers (here it is worth noting that lung cancer can occur without telomere shortening).

By the way, about women and men. Gender differences are hard to ignore, and we all know that men and women have different sex chromosomes and that men and women have different hormones. Obviously, this should affect the work of genes. Indeed, researchers have found that 37% of our genes work differently in men and women in at least one tissue. Moreover, some genes, relatively speaking, “work” only in one sex. For example, men with different DPYSL4 gene variants will have different body fat percentages. But in women, the DPYSL4 gene does not affect body fat – this does not mean that the gene does not work, just the amount of adipose tissue depends on other genes. Similarly, in men with different variants of the CLDN7 genethere will be different birth weights. In women, birth weight is linked to another gene, HKDC1 .

Many genes, whose activity depends on sex, are associated with diseases, but their “sex” differences were still unknown. Obviously, this information is useful in personalized therapy, when the patient is being treated according to his individual genetic characteristics. However, the authors of the work note that although a lot of “sex-dependent” genes were found, their activity itself does not change very much. In general, the gender genetic differences between men and women are not very large. We emphasize that this is precisely if we take it as a whole – because the genes on which, say, primary and secondary sexual characteristics depend, work in men and women in very different ways.

What else affects gene activity? For example, age – but here there is a gap in the received data. Above we said that the samples were taken mostly from people in years; in addition, more material is needed to analyze age differences across the entire genome. (By the way, it is possible that sex differences are manifested in different ways at different ages.) Some experts, according to The Scientist portal , generally strongly doubt the reliability of the results, because samples were taken from the dead, and not from living people. On the other hand, where can we find healthy volunteers who would allow them to take a piece of tissue from the bowels of their own brain? Subsequent studies are likely to greatly adjust this map of tissue gene activity, but, one way or another, the new data will have something to compare with.

Continue Reading